Clinical Trials Directory

Trials / Completed

CompletedNCT06574945

Anesthesia for Loop Electrosurgical Excision Procedure (LEEP).

Efficacy and Safety of Propofol in Combination With Different Esketamine Doses for Anesthesia During Loop Electrosurgical Excision Procedure

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Qian Wu · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

The goal of this prospective, randomized controlled study study is to investigate the efficacy and safety of propofol combined with different doses of esketamine (ESK) for anesthesia during loop electrosurgical excision procedure (LEEP).Ninety female patients undergoing LEEP were randomly allocated to three groups.It aims to answer :1.The effect of esketamine combined with propofol in respiration, circulation, etc,during LEEP. 2.The appropriate dosage of esketamine when combined with propofol in LEEP anesthesia.

Detailed description

To investigate the efficacy and safety of propofol combined with different doses of esketamine (ESK) for anesthesia during loop electrosurgical excision procedure (LEEP). Ninety female patients undergoing LEEP were randomly allocated to three groups: group P (2 mg/kg propofol + saline), group propofol + esketamine(PK)1 (1.5 mg/kg propofol + 0.5 mg/kg ESK), and group PK2 (1.5 mg/kg propofol + 0.25 mg/kg ESK). Parameters including mean arterial pressure (MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SPO2), and venous carbon dioxide (PvCO2) were recorded. Additionally, the need for supplemental propofol, jaw thrust maneuver or ventilation, postoperative awakening time, and adverse reactions were assessed.

Conditions

Interventions

TypeNameDescription
DRUGintravenous injection of propofol onlyPropofol was administered intravenously 2 mg/kg
DRUGintravenous injection of propofol +esketamineintravenous injection of 0.5 mg/kg ESK followed by 1.5 mg/kg of propofol or intravenous injection of 0.25 mg/kg ESK followed by 1.5 mg/kg of propofol

Timeline

Start date
2022-01-07
Primary completion
2022-01-07
Completion
2022-10-28
First posted
2024-08-28
Last updated
2024-08-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06574945. Inclusion in this directory is not an endorsement.